SDS Optic S.A. is starting a collaboration with Marcin Szuba, an expert in the biotechnology market
December 10, 2024
The Lublin-based company SDS Optic S.A., which is developing the fiber-optic molecular diagnostics technology inPROBE, has announced a collaboration with Marcin Szuba, an experienced expert in biotechnology fund management and supporting the growth of companies in the medical sector. This partnership aims to further strengthen SDS Optic's market position, including preparations for strategic partnerships and investments in Poland and abroad.
Marcin Szuba, a graduate of the Medical University of Warsaw and the MBA program at the University of Illinois at Urbana-Champaign, brings extensive experience gained from working with institutions such as Novo Nordisk, PHARMAC New Zealand, TFI PZU, and Trigon. His specialization includes, among others, regulatory and clinical development of medical companies as well as their international expansion.
I am honored to collaborate with SDS Optic, a company that combines passion with groundbreaking innovations in medical diagnostics. Supporting the development of technologies like inPROBE, which have the potential to enable fast and precise cancer diagnostics, is both a great challenge and a tremendous responsibility. SDS Optic's innovative approach, based on biosensors, offers potential for diagnosing cancer markers beyond the currently known HER2 marker. I believe that my experience in clinical and financial fields will help the company achieve its ambitious goals and contribute to improving healthcare standards," says Marcin Szuba.
As part of the cooperation with the Company, Marcin Szuba will be responsible for advising on business development, supporting partnership matters, financing processes, and commercialization. Mr. Szuba will also be responsible for overseeing the adaptation of documentation, processes, and the competencies of the SDS Optic team to meet FDA and EU MDR requirements. His duties will also include supporting the Business Development Director and preparing the Company for potential investments and strategic partnerships in Poland and abroad.
Establishing a partnership with Marcin Szuba is an opportunity for us to further develop and professionalize our activities. His experience in managing large medical funds and supporting commercialization processes opens up new possibilities for attracting investors and expanding into particularly demanding and competitive international markets. I believe that together we will achieve further success," adds Marcin Staniszewski, CEO of SDS Optic.
SDS Optic S.A. consistently implements its development strategy, striving to commercialize its technologies and strengthen its position in the medical industry. Cooperation with Marcin Szuba is another step towards achieving these goals.
We Care About Your Privacy
SDS Optic S.A. uses cookies to improve and customize users experience on our website. By selecting 'Accept', you consent to the use of all cookies that gather and use information about your interactions with our site to provide personalized content and enhance your digital experience. Please read our Privacy Policy for more information.